What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Clinical Trial in Seattle, Washington
NCT06853912, also referenced as PsiloStudy, is a University of Washington state-funded trial of psilocybin with psychological support for military veterans and first responders with co-occurring PTSD and alcohol use disorder. Source notes describe a single 25 mg psilocybin dose, non-directive psychological support, and integration therapy, with enrollment opening in early 2025. This is a research trial, not a public commercial service.
University of Washington Center for Novel Therapeutics in Addiction Psychiatry, Seattle, Washington
Washington complete dataset reconciliation from supplied 2026-06-15 prompt.
Source: ClinicalTrials.gov NCT06853912; UW Newsroom; Washington complete dataset prompt
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.